Synthesis, Biological Evaluation, and Molecular Modeling Investigation of Chiral Phenoxyacetic Acid Analogues with PPARα and PPARγ Agonist Activity
- 30 April 2007
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 2 (5) , 641-654
Abstract
Peroxisome proliferator‐activated receptors (PPARs) are ligand‐activated transcription factors that govern lipid and glucose homeostasis, and play a central role in cardiovascular disease, obesity, and diabetes. Thus, there is significant interest in developing new and specific agonists for these receptors. Herein we present screening results for a series of chiral phenoxyacetic acid analogues, some of which are potent PPARα agonists as well as PPARγ agonists. The stereochemistry of these compounds plays an important role in determining their activity; the S isomers were observed to be more active than the corresponding R isomers. Interestingly, for one of these analogues, the stereoselectivity toward PPARα was reversed, and for this reason docking experiments were performed to rationalize this peculiar behavior.Keywords
This publication has 55 references indexed in Scilit:
- Diabetes Mellitus: Pathogenesis and Treatment StrategiesJournal of Medicinal Chemistry, 2004
- Multiple drug targets in the management of type 2 diabetes.Current Drug Targets, 2002
- The Mechanisms of Action of PPARsAnnual Review of Medicine, 2002
- Global and societal implications of the diabetes epidemicNature, 2001
- Peroxisome proliterator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosisCurrent Opinion in Lipidology, 1999
- A Unified Nomenclature System for the Nuclear Receptor SuperfamilyCell, 1999
- Mechanism of Action of Fibrates on Lipid and Lipoprotein MetabolismCirculation, 1998
- Fatty Acids, Eicosanoids, and Hypolipidemic Agents Identified as Ligands of Peroxisome Proliferator-Activated Receptors by Coactivator-Dependent Receptor Ligand AssayMolecular Endocrinology, 1997
- The Structure−Activity Relationship between Peroxisome Proliferator-Activated Receptor γ Agonism and the Antihyperglycemic Activity of ThiazolidinedionesJournal of Medicinal Chemistry, 1996
- 1 New Hypoglycaemic Agents1994